Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chromosomal influence on hybrid cell proliferation.

J R McGill1, P J Lalley, R J Leach

  • 1Division of Molecular Genetics, Cancer Therapy and Research Center, San Antonio, TX 78229.

Cell Proliferation
|July 1, 1992
PubMed
Summary

Cell fusion can suppress cancer growth. Introducing chromosomes from other species into hybrid cells slowed their division rate, suggesting increased genetic material reduces cell division potential.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improvements in Survival and Clinical Benefit With Gemcitabine as First-Line Therapy for Patients With Advanced Pancreas Cancer: A Randomized Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023
Same author

Positron emission tomography (PET) as a predictive measure in patients with metastatic pancreatic cancer and normal CA19-9 levels at baseline.

Annals of oncology : official journal of the European Society for Medical Oncology·2016
Same author

Positron emission tomography response evaluation from a randomized phase III trial of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone for patients with metastatic adenocarcinoma of the pancreas.

Annals of oncology : official journal of the European Society for Medical Oncology·2016
Same author

CA19-9 decrease at 8 weeks as a predictor of overall survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2016
Same author

Phase II trial of vatalanib in patients with advanced or metastatic pancreatic adenocarcinoma after first-line gemcitabine therapy (PCRT O4-001).

Cancer chemotherapy and pharmacology·2014
Same author

Phase I pharmacokinetic and pharmacodynamic study of the pan-PI3K/mTORC vascular targeted pro-drug SF1126 in patients with advanced solid tumours and B-cell malignancies.

European journal of cancer (Oxford, England : 1990)·2012

Area of Science:

  • Cell biology
  • Genetics
  • Cancer research

Background:

  • Experimental fusion of normal and cancer cells typically results in hybrid cells that lose their tumorigenic properties.
  • Understanding the mechanisms behind this growth suppression is crucial for cancer therapy development.

Purpose of the Study:

  • To investigate the phenotypic phenomenon of growth suppression in hybrid cells in vitro.
  • To determine the effect of inter-species chromosome transfer on cell division rates.

Main Methods:

  • Examined the doubling times of somatic cell hybrids.
  • Utilized inter-species hybrids containing single or multiple chromosomes from a donor species.
  • Cultured hybrid cell lines in vitro.

Main Results:

Related Experiment Videos

  • All examined hybrid cell lines showed prolonged cell population doubling times.
  • The extension in doubling time was proportional to the number of transferred chromosomes present in the hybrid lines.

Conclusions:

  • The presence of additional chromosomes from another species can inhibit cell division in vitro.
  • These findings support the hypothesis that an increased genetic burden may reduce cellular division potential.